Glassman Wealth Services’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-67
| Closed | -$630 | – | 714 |
|
|
2023
Q4 | $630 | Sell |
67
-36
| -35% | -$339 | ﹤0.01% | 1669 |
|
|
2023
Q3 | $1.15K | Buy |
+103
| New | +$1.15K | ﹤0.01% | 1510 |
|
|
2022
Q2 | – | Sell |
-5
| Closed | – | – | 1759 |
|
|
2022
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 1722 |
|
|
2021
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 1705 |
|
|
2021
Q3 | $0 | Buy |
+5
| New | – | ﹤0.01% | 1651 |
|
|
2017
Q2 | – | Sell |
-3,083
| Closed | -$95K | – | 575 |
|
|
2017
Q1 | $95K | Sell |
3,083
-3,580
| -54% | -$110K | 0.07% | 119 |
|
|
2016
Q4 | $223K | Buy |
+6,663
| New | +$223K | 0.16% | 70 |
|
|
2016
Q2 | – | Sell |
-3,580
| Closed | -$105K | – | 434 |
|
|
2016
Q1 | $105K | Hold |
3,580
| – | – | 0.1% | 104 |
|
|
2015
Q4 | $118K | Sell |
3,580
-1,308
| -27% | -$43.1K | 0.11% | 104 |
|
|
2015
Q3 | $177K | Hold |
4,888
| – | – | 0.16% | 76 |
|
|
2015
Q2 | $220K | Hold |
4,888
| – | – | 0.18% | 61 |
|
|
2015
Q1 | $150K | Buy |
+4,888
| New | +$150K | 0.12% | 85 |
|